Stockreport

Annexon Announces Pricing of $125 Million Underwritten Public Offering

Annexon, Inc. - common stock  (ANNX) 
PDF BRISBANE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapi [Read more]